Get started
Author

Hongsong Bai

Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study
2022 · Zhenrong Yang, Hongsong Bai, et al. · EClinicalMedicine · 26
PDF
Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
2021 · Hongzhe Shi, Wen Zhang, et al. · Cancer Research and Treatment · 22
PDF
Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis
2022 · Hongsong Bai, Weixing Jiang, et al. · BMC Urology · 11
PDF
Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma
2023 · Ruiyang Xie, Bingqing Shang, et al. · Cancer Medicine · 10
PDF
Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
2022 · Zhenrong Yang, Hongsong Bai, et al. · Translational Andrology and Urology · 10
PDF
Disitamab vedotin (DV, RC48-ADC) combined with cadonilimab (anti-PD-1/CTLA-4 bispecific antibody) in patients with locally advanced or metastatic urothelial carcinoma (la/mUC): An open-label, single-arm, phase II study.
2024 · Wasilijiang Wahafu, Shuqing Wei, et al. · Journal of Clinical Oncology · 8
PDF
Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report
2022 · Hongsong Bai, Huifu Han, et al. · Journal of International Medical Research · 4
Efficacy and safety of tislelizumab combined with chemotherapy for locally advanced penile cancer: a prospective, single-arm clinical study
2025 · Xingli Shan, Hongsong Bai, et al. · British Journal of Cancer · 2
Updated results from a phase II study of perioperative disitamab vedotin (RC48-ADC) plus cadonilimab (AK104) for HER2-expressing muscle-invasive bladder cancer (MIBC).
2025 · Sujun Han, Feiya Yang, et al. · Journal of Clinical Oncology · 2
Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma
2024 · Honglei Cui, Jie Wu, et al. · European Urology Open Science · 2
Preliminary results from a phase II study to evaluate the efficacy and safety of perioperative disitamab vedotin (RC48-ADC) plus cadonilimab (AK104, PD-1/CTLA-4 bispecific antibody) for HER2-expressing muscle-invasive bladder cancer (MIBC).
2024 · Sujun Han, Yong Zhang, et al. · Journal of Clinical Oncology · 2
Albumin-bound paclitaxel, cisplatin, and bleomycin combination with tislelizumab for stage IV squamous cell carcinoma of the penis without surgical indications: A single-arm, single-center prospective phase II clinical study.
2024 · Xingli Shan, Hongsong Bai, et al. · Journal of Clinical Oncology · 2
Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer
2020 · Linjun Hu, Qinxin Zhao, et al. · Cancer Management and Research · 1
PDF
Pd51-07 Oncologic and Functional Effectiveness of Neoadjuvant Chemotherapy Followed by Either Bladder-sparing Surgery Plus Concurrent Chemoradiotherapy or Cystectomy for Muscle-invasive Bladder Cancer: Preliminary Results of a Prospective Phase Ii Study
2020 · Jianzhong Shou*, Chuanzhen Cao, et al. · The Journal of Urology · 1
Modified docetaxel regimen for prostate cancer patients who got poor tolerance to chemotherapy
2017 · Linjun Hu, Changling Li, et al. · Zhonghua miniao waike zazhi · 1
Prognostic Value of Preoperative Fibrinogen in Metastatic Clear Cell Renal Cell Carcinoma Patients Undergoing Cytoreductive Nephrectomy
2026 · Honglei Cui, Gan Du, et al. · Clinical Genitourinary Cancer
Cognitive fusion targeted biopsy is not inferior to systematic biopsy in metastatic prostate cancer: a single-center, paired study
2026 · Yonghai Chen, Xingli Shan, et al. · BMC Urology
Real-world PSA kinetics and depth of response with ARPI-based triplet therapy in metastatic hormone-sensitive prostate cancer: A single-center retrospective cohort analysis.
2026 · Yonghai Chen, Huoshan Ning, et al. · Journal of Clinical Oncology
Neutrophil extracellular traps in relation to efficacy of systemic therapy for metastatic renal cell carcinoma.
2024 · Rui-Yang Xie, Bing-Qing Shang, et al. · Journal of Clinical Oncology
Serum IgG: A potential biomarker for predicting the efficacy of systemic therapy in metastatic renal cell carcinoma.
2024 · Honglei Cui, Jie Wu, et al. · Journal of Clinical Oncology
Preparation of 125 I seed sources for implantation therapy of prostate cancer
2006 · Hao Fan, Xiaodong Jin, et al.
Works count: 21
Citation count: 104
H-index: 6
I10-index: 5
Year
Topic
Type